CE Catch Up 2019 (MUSC, Charleston)

CE Catch Up

Hosted by Alpha Kappa Chapter, Phi Delta Chi, MUSC College of Pharmacy

March 23, 2019

9:00 am to 4:30 pm

MUSC Biomedical Engineering Building

68 President Street, Charleston, SC 29425

REGISTRATION DEADLINE: MARCH 8, 2019 (no refunds after this date)

Register online at: https://www.surveymonkey.com/r/PDC_CE_Registration

Credit card payments accepted online*: https://squareup.com/store/pdc

*A convenience fee of 3.5% will be added to your tuition to cover online payment processing.

Check payments accepted:

Please make checks payable to Phi Delta Chi

Mail checks to Attn: Faye Ratliff, South Carolina College of Pharmacy, 280 Calhoun Street, MUSC 140, QE225, Charleston, SC 29425

For questions about registration, please contact Madison Salam – salamm@musc.edu

Program Agenda:

8:00 am- 9:00 am	Check In and Breakfast
9:00 am- 10:00 am	Once in a lifetime: bridging the generational gap in medicine Brittany Jones, PharmD; Ambulatory Care Clinical Specialist and Adjunct Assistant Professor, Medical University of South Carolina, Charleston, SC ACPE UAN 0062-9999-19-065-L01-P/T (1.0 credit hours, 0.1 CEU; disease state management/drug therapy; application-based) Learning Objectives: At the completion of this activity, the pharmacist and pharmacy technician will be able to: Discuss trends in epidemiology of the average lifespan over the past century Assess the physiological changes occurring at different stages of life and how they affect medicine within the body Differentiate between the generations including key characteristics of each group Recommend ways for which the pharmacist and pharmacy technician can increase adherence across the generational gap
10:00 am-10:15 am	Break
10:15 am- 12:15 pm	New Drug Update 2018-2019 C. Wayne Weart, Pharm.D., BCPS, FASHP, FAPhA; Professor Emeritus, Department of Clinical Pharmacy and Outcomes Sciences, MUSC College of Pharmacy ACPE UAN 0062-9999-19-063-L01-P/T (2.0 credit hours, 0.2 CEU; disease state management/drug therapy; knowledge-based) Learning Objectives: At the conclusion of the program, the pharmacist will be able to: Discuss the new guidelines for type 2 diabetes, lipids, resistant hypertension and HFrEF, the evidence on which they are based, and how to apply them in selected patients Describe the current information concerning newly FDA approved medications (pharmacology, pharmacokinetics, efficacy and safety data, drug interactions, dosing, monitoring, and cost) in the selection of evidence-based pharmacotherapy At the conclusion of the program, the pharmacy technician will be able to: Discuss the new guidelines for type 2 diabetes, lipids, resistant hypertension and HFrEF and the evidence on which they are based Describe the current information concerning newly FDA approved medications (pharmacology, pharmacokinetics, efficacy and safety data, drug interactions, dosing, monitoring, and cost)
12:15 pm- 1:00 pm	Lunch
1:00 pm- 2:00 pm	Medication Errors in Solid Organ Transplant: Leveraging Technology to Reduce Risk Dr. James Fleming, PharmD, BCPS; Clinical Pharmacy Specialist and Affiliate Associate Professor, Medical University of South Carolina, Charleston, SC ACPE UAN 0062-9999-19-062-L05-P/T (1.0 credit hours, 0.1 CEU; patient safety; application-based) Learning Objectives: At the conclusion of the program, the pharmacist and pharmacy technician will be able to: Describe the incidence of medication errors in solid organ transplant Examine unique risk factors for medication errors in transplant patients Appraise the potential for technological solutions to prevent medication errors
2:00 pm- 3:00 pm	Piecing together the pain puzzle: exploring multimodal non-opioid pain management strategies Dr. Emmeline Tran, PharmD, BCPS; Assistant Professor, Medical University of South Carolina; Internal Medicine Clinical Specialist, Ralph H. Johnson VA Medical Center; Charleston, SC ACPE UAN 0062-9999-19-064-L01-P/T (1.0 credit hours, 0.1 CEU; disease state management/drug therapy; application-based) Learning Objectives: At the conclusion of the program, the pharmacist will be able to: Identify challenges in pain management in the acute care setting Discuss multimodal pain management strategies Evaluate recent literature pertinent to the use of nonopioid analgesics Integrate recent evidence-based recommendations into clinical practice At the completion of this activity, the pharmacy technician will be able to: Identify challenges in pain management in the acute care setting Define multimodal pain management Discuss medications used in multimodal pain management
3:00 pm- 3:15 pm	Break
3:15 pm- 4:15 pm	Updates in treatment of cancer-associated thrombosis and HIT Dr. Nicole Bohm, PharmD, BCPS; Associate Professor and Internal Medicine Clinical Specialist; Medical University of South Carolina, Charleston, SC ACPE UAN 0062-9999-19-066-L01-P/T (1.0 credit hours, 0.1 CEU; disease state management/drug therapy; application-based) Learning Objectives: At the conclusion of the program, the pharmacist will be able to: Contrast outcomes data for direct oral anticoagulants (DOACs) to historical standard of care anticoagulants in cancer-associated thrombosis Recognize patients with heparin induced thrombocytopenia who may be candidates for DOACs Identify patient characteristics that may compromise DOAC safety or efficacy At the completion of this activity, the pharmacy technician will be able to: Recognize common dosing strategies for DOACs in VTE Identify patient characteristics that may impact DOAC safety or efficacy
4:15 pm- 4:30 pm	Wrap Up and Accessing CE Documentation

Date: Mar 23, 2019 09:00 AM - 04:30 PM

CE Hours

6.00

CE Units

0.600

Activity Type

Knowledge-Based and Application-Based

Target Audience(s)

Pharmacists
Pharmacy Technicians

Accreditation(s)

The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Co-Sponsor(s)

Requirements for CE Credit

To claim credit for a session, participants must sign-in at and attend the entire session. Participants must complete online evaluations (providing their correct NABP e-profile number and day/month of birth) in order to have credit reported to the NABP CPE Monitor. Evaluations should be completed and credit claimed within 30 days of the live program to ensure transmission to the NABP CPE Monitor. The NABP CPE Monitor will not accept any credit claimed and transmitted greater than 60 days from the date of the live program.

To verify your NABP e-Profile number and day/month of birth on record with NABP, please visit their website by selecting the link below.

Sat, Mar 23, 2019

Once in a lifetime: bridging the generational gap in medicine

At the completion of this activity, the pharmacist and pharmacy technician will be able to:

Discuss trends in epidemiology of the average lifespan over the past century
Assess the physiological changes occurring at different stages of life and how they affect medicine within the body
Differentiate between the generations including key characteristics of each group
Recommend ways for which the pharmacist and pharmacy technician can increase adherence across the generational gap

Speaker(s)/Author(s)

Brittany Jones, PharmD
Ambulatory Care Clinical Specialist and Adjunct Assistant Professor, Medical University of South Carolina

Activity Number

0062-9999-19-065-L01-P/T

Date: 03/23/19

Time: 09:00 AM - 10:00 AM

CE Hours

1.00

New Drug Update 2018-2019

At the completion of this activity, the pharmacist will be able to:

Discuss the new guidelines for type 2 diabetes, lipids, resistant hypertension and HFrEF, the evidence on which they are based, and how to apply them in selected patients
Describe the current information concerning newly FDA approved medications (pharmacology, pharmacokinetics, efficacy and safety data, drug interactions, dosing, monitoring, and cost) in the selection of evidence-based pharmacotherapy

At the completion of this activity, the pharmacy technician will be able to:

Discuss the new guidelines for type 2 diabetes, lipids, resistant hypertension and HFrEF and the evidence on which they are based
Describe the current information concerning newly FDA approved medications (pharmacology, pharmacokinetics, efficacy and safety data, drug interactions, dosing, monitoring, and cost)

Speaker(s)/Author(s)

C. Wayne Weart, PharmD, FASHP, FAPhA
Professor Emeritus Department of Clinical Pharmacy and Outcome Sciences and Professor of Family Medicine, MUSC College of Pharmacy

Activity Number

0062-9999-19-063-L01-P/T

Date: 03/23/19

Time: 10:15 AM - 12:15 AM

CE Hours

2.00

Medication Errors in Solid Organ Transplant: Leveraging Technology to Reduce Risk

At the completion of this activity, the pharmacist and pharmacy technician will be able to:

Describe the incidence of medication errors in solid organ transplant
Examine unique risk factors for medication errors in transplant patients
Appraise the potential for technological solutions to prevent medication errors

Speaker(s)/Author(s)

James Fleming, PharmD, BCPS
Clinical Pharmacy Specialist and Affiliate Associate Professor, Medical University of South Carolina

Activity Number

0062-9999-19-062-L05-P/T

Date: 03/23/19

Time: 01:00 PM - 02:00 PM

CE Hours

1.00

Piecing together the pain puzzle: exploring multimodal non-opioid pain management strategies

At the completion of this activity, the pharmacist will be able to:

Identify challenges in pain management in the acute care setting
Discuss multimodal pain management strategies
Evaluate recent literature pertinent to the use of nonopioid analgesics
Integrate recent evidence-based recommendations into clinical practice

At the completion of this activity, the pharmacy technician will be able to:

Identify challenges in pain management in the acute care setting
Define multimodal pain management
Discuss medications used in multimodal pain management

Speaker(s)/Author(s)

Emmeline Tran, PharmD, BCPS
Assistant Professor, Medical University of South Carolina

Activity Number

0062-9999-19-064-L01-P/T

Date: 03/23/19

Time: 02:00 PM - 03:00 PM

CE Hours

1.00

Updates in treatment of cancer-associated thrombosis and HIT

At the completion of this activity, the pharmacist will be able to:

Contrast outcomes data for direct oral anticoagulants (DOACs) to historical standard of care anticoagulants in cancer-associated thrombosis
Recognize patients with heparin induced thrombocytopenia who may be candidates for DOACs
Identify patient characteristics that may compromise DOAC safety or efficacy

At the completion of this activity, the pharmacy technician will be able to:

Recognize common dosing strategies for DOACs in VTE
Identify patient characteristics that may impact DOAC safety or efficacy

Speaker(s)/Author(s)

Nicole Bohm, PharmD, BCPS
Associate Professor, Department of Clinical Pharmacy and Outcomes Sciences, Medical University of South Carolina

Activity Number

0062-9999-19-066-L01-P/T

Date: 03/23/19

Time: 03:15 PM - 04:15 PM

CE Hours

1.00